NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
421 Halland

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 690 6.4% 81 0.8% 13 0.1% 1 0.0% 6 0.1% 4 0.0% 9988 92.6% 10783 100.0%
ASCUS 409 33.4% 171 14.0% 67 5.5% 2 0.2% 2 0.2% 5 0.4% 568 46.4% 1224 100.0%
LSIL 125 25.3% 156 31.6% 66 13.4% 1 0.2% . . 4 0.8% 142 28.7% 494 100.0%
Atypical glandular cells/AGC 10 50.0% 2 10.0% . . 3 15.0% 2 10.0% 1 5.0% 2 10.0% 20 100.0%
Unclear atypia 16 43.2% 5 13.5% 6 16.2% 1 2.7% 2 5.4% . . 7 18.9% 37 100.0%
ASC-H 39 22.4% 44 25.3% 81 46.6% 1 0.6% 4 2.3% 1 0.6% 4 2.3% 174 100.0%
HSIL 12 8.4% 23 16.1% 97 67.8% 2 1.4% 6 4.2% . . 3 2.1% 143 100.0%
Suspected Adenocarcinom . . . . . . . . 1 100.0% . . . . 1 100.0%
Totalt 1301 10.1% 482 3.7% 330 2.6% 11 0.1% 23 0.2% 15 0.1% 10714 83.2% 12876 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M80703, M81403, M81406, M83803